Supply of Medicinal Products
Original notice title
France – Pharmaceutical products – UniHA_Fourniture de médicaments
Opportunity Score
Why this score?
Opportunity
80 / 100
Complexity
60 / 100
Risk factors
EU funding flag: structured data says EU-funded, XML notice says no EU funds. This may affect contract terms or eligibi...
Award criteria and detailed selection requirements are not provided in the notice.
Restricted procedure — pre-qualification required
Deep Portfolio Analysis
Uses:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications
Overview
Strong opportunityKey Facts
- EUR 834.6M estimated value
- Dynamic Purchasing System (DPS)
- Supplies contract
- 1 lot
- Duration 120 MONTH
- Supply of medicinal products from identified therapeutic areas (annex 1 of the CCTP).
- Supply of equivalent medical devices meeting same technical requirements.
Show full summary
This is a corrigendum of a Dynamic Purchasing System (SAD) for the supply of pharmaceutical products to member establishments of UniHA in France. The DPS covers various therapeutic areas and lasts 120 months. The estimated total value is €834,612,170. The procedure is restricted, and applications can be submitted until 24 November 2031. Note: There is an inconsistency regarding EU funding (structured data says EU-funded, XML notice says no EU funds).
Risks
EU funding flag: structured data says EU-funded, XML notice says no EU funds. This may affect contract terms or eligibi...
Award criteria and detailed selection requirements are not provided in the notice.
Restricted procedure — pre-qualification required
Analysis may be incomplete
Only part of the procurement documentation was analyzed. Additional eligibility requirements, certificates, or submission documents may exist in the remaining tender documentation.
Key Requirements
Technical
- Admission to the Dynamic Purchasing System (SAD) is required.
- Selection based on economic, financial, and professional capacity as per article 7.2 of the RC.
- Candidates may be asked to update their application during the DPS validity.
Award Criteria
Lot 1
Buyer
Name
Location
LYON, FRA
Website
Buyer profile
Identifier
130 002 223 00043
Activity
Health
Lots (1)
LOT-0001
Supply of Medicinal Products
Supply of medicinal products from identified therapeutic areas (annex 1) and equivalent medical devices to UniHA member establishments.
EUR 834.6M
Estimated value
Location
Duration
Category
Award Criteria
Deadline
Award details
Le marché a pour objet la fourniture de médicaments des aires thérapeutiques identifiés dans l'annexe 1 du CCTP du présent SAD (et le cas échéant, des dispositifs médicaux équivalents répondants aux mêmes exigences techniques) pour le compte des établissements adhérents à UniHA.
Value note
Show original TED data
Original lot title
UniHA_Fourniture de médicaments
Original TED description
Le marché a pour objet la fourniture de médicaments des aires thérapeutiques identifiés dans l'annexe 1 du CCTP du présent SAD (et le cas échéant, des dispositifs médicaux équivalents répondants aux mêmes exigences techniques) pour le compte des établissements adhérents à UniHA.
Procurement Details
- Publication date
- 13 Apr 2026
- Languages
- French
Reference metadata
- Legal basis
- 32014L0024
Reference IDs
- Tender ID
- 252871-2026
Documents (1)
Similar tenders
Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells zum Wirkstoff Ipratropiumbromid (ATC-Code nach WHO: R03BB01)
Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells über Arzneimittel mit dem Handelsnamen Orylmyte(R) (ATC-Code nach WHO: V01AA03)
Belgium – Pharmaceutical products – Antimycotica
Denmark – Pharmaceutical products – Amgros 2027 1.1170.a
France – Pharmaceutical products – 26-10 : ACCORD-CADRE DE FOURNITURE DE MÉDICAMENTS 2026
Bulgaria – Pharmaceutical products – Динамична система за покупки за доставка на лекарствени продукти за Медицински институт на МВР
Opportunity Score
Why this score?
Opportunity
80 / 100
Complexity
60 / 100
Risk factors
EU funding flag: structured data says EU-funded, XML notice says no EU funds. This may affect contract terms or eligibi...
Award criteria and detailed selection requirements are not provided in the notice.
Restricted procedure — pre-qualification required
Deep Portfolio Analysis
Uses:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications